Antibody for anti-claudin 18A2 and use thereof
US11111295B2 · kind B2 · utility
4Cited by
10References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2017 |
| Grant date | Sep 7, 2021 |
| Priority date | — |
| Expiry date | Nov 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/03
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided in the present invention is an antibody for anti-claudin 18A2 and an immune effector cell targeting claudin 18A2. Also provided are methods for inducing cell death and treating tumours.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.